<html xmlns="http://www.w3.org/1999/xhtml"><head> <style type="text/css">
         	     		 
         	    a                          {background : #ffffff; }
         	    article                    {border-style : dotted; border-width : 2px; }
         		 	
         		 	div                        {background : #ffffcc;}
         		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
         		 	div.ack                    {border-style : solid ; border-color : red; margin
         : 2em; }
         		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin
         1em;}
         		 	div.boxed-text             {margin : 5em; border-style : solid;}
         		 	div.contrib-group          {margin : 1em; }
         		 	div.fig                    {border-style : solid; border-width : 2px; margin :
         2em; }
         		 	div.funding                {font-weight : bold ; font-size : 16pt;}
         		 	div.given-names            {font-style : italic;}
         		 	div.intro                  {border-style : inset; margin : 5px;}
         		 	div.introduction           {border-style : inset; margin : 5px;}
         		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin
         1em;}
         		 	div.journal-title-group    {background : #ffeeee;}
         		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
         		 	div.kwd                    {font-style : italic}
         		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
         		 	div.name                   {font-weight : bold;}
         		 	div.alt-title              {font-style : italic; font-size : 12px;}
         		 	
         		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
         		 	div.title                  {font-family : courier; font-weight : bold;
         		 	                            font-size : 16pt; margin : 5px;}
         		 	
         		 	div.materials_methods      {border-style : double; margin : 5px; }
         		 	div.methods                {border-style : double; margin : 5px; }
         		 	
         		 	div.results                {border-style : solid; margin : 5px;}
         		 	div.background             {border-style : dotted; margin : 5px;}
         		 	
         		 	div.discussion             {border-style : groove; margin : 5px;}
         		 	div.conclusion             {border-style : ridge; margin : 5px;}
         		 	div.conclusions             {border-style : ridge; margin : 5px;}
         		 	div.supplementary-material {border-style : inset; margin : 5px;}
         		 	div.abbreviations          {border-style : double; border-color : red; margin
         : 5px;}
         		 	div.competinginterests     {border-style : double; border-color : blue; margin
         : 5px;}
         		 	div.acknowledgements       {border-style : double; border-color : green; margin
         : 5px;}
         		 	div.authors_contributions   {border-style : double; border-color : purple; margin
         : 5px;}
         		 	
         		 	div.publisher              {border-style : outset; margin : 5px;}
         		 	div.fn-type-conflict       {background : #f88; }
         		 	div.fn-type-con            {background : #ddf; }
         		 	div.fn-type-other          {background : #ddd; }
         		 	
         		 	div.unknown                {background : #ffd;
         									 	  border-style : solid;
         									 	  border-width : 1px;
         									 	  padding : 2 px;}
         		 	  
         	    table                      {background : #ffffdd;}
         		 	tr                         {background : #ddddff; padding : 1px;}
         		 	
         		 	span                       {background : #ffcccc;}
         		 	
         		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
         		 	span.collab                {background : #ddffff; }
         		 	span.comment               {font-family : courier; font-size : 6px; background
         : #ffaaff;}
         		 	span.contrib               {background : #ffffff;}
         		 	span.corresp               {background : #ddffdd; }
         		 	span.doi                   {background : #ffffff;}
         		 	span.email                 {font-family : courier; }
         		 	span.etal                  {font-style : italic;}
         		 	span.fpage                 {font-family : courier;}
         		 	span.given-names           {background : #ffffff;}
         		 	span.iso-abbrev            {background : #ffffff;}
         		 	span.issn-epub             {background : #ffffff;}
         		 	span.issn-ppub             {background : #ffffff;}
         		 	span.journal-title         {background : #ffffff;}
         		 	span.lpage                 {font-family : courier;}
         		 	span.mixed-article-title   {font-style : italic ;}
         		 	span.nlm-ta                {background : #ffffff;}
         		 	span.pmc                   {background : #ffffff;}
         		 	span.pmcid                 {background : #ffffff;}
         		 	span.pmid                  {background : #ffffff;}
         		 	span.publisher             {background : #ffffff;}
         		 	span.publisher-id          {background : #ffffff;}
         		 	span.publisher-name        {background : #ffffff;}
         		 	span.source                {background : #ffffff;}
         		 	span.subject               {background : #ffffff;}
         		 	span.surname               {background : #ffffff;}
         		 	span.volume                {font-family : courier; font-weight : bold;}
         		 	span.year                  {font-family : courier ; font-style : italic;}
         			
      </style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"> <span class="nlm-ta" title="nlm-ta">Neurol Genet</span> <span class="iso-abbrev" title="iso-abbrev">Neurol Genet</span> <span class="hwp" title="hwp">nng</span> <span class="publisher-id" title="publisher-id">NNG</span> <div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"> <span class="journal-title" tagx="journal-title" title="journal-title">Neurology: Genetics</span> </div> <span class="issn-epub" tagx="issn" title="issn-epub">2376-7839</span> <div class="publisher" tagx="publisher" title="publisher"> <span class="publisher-name" tagx="publisher-name" title="publisher-name">Wolters Kluwer</span> <span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">Baltimore</span> </div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"> <span class="pmcid" title="pmcid"> pmcid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/6878943">6878943</a> </span> <span class="publisher-id" title="publisher-id">NG2019011056</span> <span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.1212/NXG.0000000000000377">10.1212/NXG.0000000000000377</a> </span> <div class="article-categories" title="article-categories">
: <span class="subject" title="subject">91</span> <span class="subject" title="subject">161</span>: <span class="subject" title="subject">Clinical/Scientific Notes</span> </div> <div class="title-group"> <div class="article-title" title="article-title">
Galloping tongue syndrome in a <i>PRRT2</i> mutation carrier </div> </div> <div class="contrib-group" title="contrib-group"> <span class="contrib" title="contrib"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Vilas</span> <span class="given-names" tagx="given-names" title="given-names">Dolores</span> </span> <span class="degrees" tagx="degrees" title="degrees">MD, PhD</span> <div class="unknown" title="author-comment" tag="author-comment"> <p> </p><ol> <div class="title" tagx="title" title="title">
Scientific Advisory Boards:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Gifts:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Funding for Travel or Speaker Honoraria:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Editorial Boards:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Patents:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Publishing Royalties:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Employment, Commercial Entity:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Consultancies:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Speakers' Bureaus:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Other Activities:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Clinical Procedures or Imaging Studies:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Research Support, Commercial Entities:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Research Support, Government Entities:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Research Support, Academic Entities:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Research Support, Foundations and Societies:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Stock/Stock Options/Board of Directors Compensation:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
License Fee Payments, Technology or Inventions:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Royalty Payments, Technology or Inventions:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Stock/Stock Options, Research Sponsor:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Stock/Stock Options, Medical Equipment &amp;amp; Materials:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Legal Proceedings:</div> <li> <p>NONE</p> </li> </ol> <p /> </div> </span> <span class="contrib" title="contrib"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Marcé-Grau</span> <span class="given-names" tagx="given-names" title="given-names">Anna</span> </span> <span class="degrees" tagx="degrees" title="degrees">PhD</span> <div class="unknown" title="author-comment" tag="author-comment"> <p> </p><ol> <div class="title" tagx="title" title="title">
Scientific Advisory Boards:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Gifts:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Funding for Travel or Speaker Honoraria:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Editorial Boards:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Patents:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Publishing Royalties:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Employment, Commercial Entity:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Consultancies:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Speakers' Bureaus:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Other Activities:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Clinical Procedures or Imaging Studies:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Research Support, Commercial Entities:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Research Support, Government Entities:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Research Support, Academic Entities:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Research Support, Foundations and Societies:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Stock/Stock Options/Board of Directors Compensation:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
License Fee Payments, Technology or Inventions:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Royalty Payments, Technology or Inventions:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Stock/Stock Options, Research Sponsor:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Stock/Stock Options, Medical Equipment &amp;amp; Materials:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Legal Proceedings:</div> <li> <p>NONE</p> </li> </ol> <p /> </div> </span> <span class="contrib" title="contrib"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Macaya</span> <span class="given-names" tagx="given-names" title="given-names">Alfons</span> </span> <span class="degrees" tagx="degrees" title="degrees">PhD</span> <div class="unknown" title="author-comment" tag="author-comment"> <p> </p><ol> <div class="title" tagx="title" title="title">
Scientific Advisory Boards:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Gifts:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Funding for travel or speaker honoraria:</div> <li> <p>Illumina, speaker honoraria</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Editorial Boards:</div> <li> <p>European Journal of Paediatric Neurology, Editorial Board, 2018-2019</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Patents:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Publishing Royalties:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Employment, Commercial Entity:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Consultancies:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Speakers' Bureaus:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Other Activities:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Clinical Procedures or Imaging Studies:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Research Support, Commercial Entities:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Research Support, Government Entities:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Research Support, Academic Entities:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Research Support, Foundations and Societies:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Stock/Stock Options/Board of Directors Compensation:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
License Fee Payments, Technology or Inventions:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Royalty Payments, Technology or Inventions:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Stock/Stock Options, Research Sponsor:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Stock/Stock Options, Medical Equipment &amp;amp; Materials:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Legal Proceedings:</div> <li> <p>NONE</p> </li> </ol> <p /> </div> </span> <span class="contrib" title="contrib"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Valls-Solé</span> <span class="given-names" tagx="given-names" title="given-names">Josep</span> </span> <span class="degrees" tagx="degrees" title="degrees">MD, PhD</span> <div class="unknown" title="author-comment" tag="author-comment"> <p> </p><ol> <div class="title" tagx="title" title="title">
Scientific Advisory Boards:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Gifts:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Funding for Travel or Speaker Honoraria:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Editorial Boards:</div> <li> <p>Associate Editor for Clinical Neurophysiology PracticeDeputy Editor for Brain Stimulation</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Patents:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Publishing Royalties:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Employment, Commercial Entity:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Consultancies:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Speakers' Bureaus:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Other Activities:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Clinical Procedures or Imaging Studies:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Research Support, Commercial Entities:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Research Support, Government Entities:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Research Support, Academic Entities:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Research Support, Foundations and Societies:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Stock/Stock Options/Board of Directors Compensation:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
License Fee Payments, Technology or Inventions:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Royalty Payments, Technology or Inventions:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Stock/Stock Options, Research Sponsor:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Stock/Stock Options, Medical Equipment &amp;amp; Materials:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Legal Proceedings:</div> <li> <p>NONE</p> </li> </ol> <p /> </div> </span> <span class="contrib" title="contrib"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Tolosa</span> <span class="given-names" tagx="given-names" title="given-names">Eduard</span> </span> <span class="degrees" tagx="degrees" title="degrees">MD, PhD</span> <div class="unknown" title="author-comment" tag="author-comment"> <p> </p><ol> <div class="title" tagx="title" title="title">
Scientific Advisory Boards:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Gifts:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Funding for travel or speaker honoraria:</div> <li> <p>honoraria as a speaker for UCB, Boeringer Ingelheim, Novartis, Abbot, Medtronic, Solvay, GSK, Teva </p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Editorial Boards:</div> <li> <p>Editorial advisory board member for Journal Neurological Sciencies</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Patents:</div> <li> <p>Date of filing: 17.12.2015 Title: method for the sub-classification of patients suffering from parkinson disease </p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Publishing Royalties:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Employment, Commercial Entity:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Consultancies:</div> <li> <p>The Michael J Fox foundation for Parkinson's Disease Novartis UCB Abbot Teva</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Speakers' Bureaus:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Other Activities:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Clinical Procedures or Imaging Studies:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Research Support, Commercial Entities:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Research Support, Government Entities:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Research Support, Academic Entities:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Research Support, Foundations and Societies:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Stock/Stock Options/Board of Directors Compensation:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
License Fee Payments, Technology or Inventions:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Royalty Payments, Technology or Inventions:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Stock/Stock Options, Research Sponsor:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Stock/Stock Options, Medical Equipment &amp;amp; Materials:</div> <li> <p>NONE</p> </li> </ol> <p /> <p> </p><ol> <div class="title" tagx="title" title="title">
Legal Proceedings:</div> <li> <p>NONE</p> </li> </ol> <p /> </div> </span> <span class="citation_author_institution" id="">[], </span> </div> <div class="author-notes" title="author-notes"> <div class="corresp" title="corresp"> <b>Correspondence</b> Dr. Tolosa <span class="email" tagx="email" title="email">etolosa@clinic.cat</span> </div> <div class="fn-type-financial-disclosure" title="financial-disclosure"> <p>Go to <a href="https://ng.neurology.org/content/5/6/e372/tab-article-info">Neurology.org/NG</a> for full disclosures. Funding information is provided at the end of the article. </p> </div> <div class="fn-type-other" title="other"> <p>The Article Processing Charge was funded by the authors.</p> </div> </div> <span class="pub-date-collection" title="pub-date-collection">collection: <span>2019-12</span> </span> <span class="pub-date-epub" title="pub-date-epub">epub: <span>2019-11-11</span> </span> <span class="pub-date-pmc-release" title="pub-date-pmc-release">pmc-release: <span>2019-11-11</span> </span> <span class="volume" tagx="volume" title="volume">5</span> <span class="issue" tagx="issue" title="issue">6</span> <span class="elocation-id" tagx="elocation-id" title="elocation-id">e377</span> <span class="history" title="history"> <span class="received" title="received">received: 2019-5-28</span> <span class="accepted" title="accepted">accepted: 2019-10-09</span> </span> <div class="permissions"> <span class="copyright" title="copyright">(C) <span class="copyright-holder" tagx="copyright-holder" title="copyright-holder">American Academy of Neurology</span>, <span class="copyright-year" tagx="copyright-year" title="copyright-year">2019</span> </span> <span class="license" title="license"> <span class="license-p" title="license-p">This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND)</a>, which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. </span> </span> </div> <a class="self-uri" href="NG2019011056.pdf" title="self-uri">NG2019011056.pdf</a> <div class="custom-meta-group" title="custom-meta-group"> <meta name="OPEN-ACCESS" value="TRUE" /> <meta name="special-property" value="video" /> </div> </div> </div> <div class="body" title="body"> <p>Abnormal lingual movements are not uncommon. A rare lingual syndrome consisting of involuntary wave-like lingual movements has been labeled as "galloping tongue." <sup> <a href="#R1">1</a> </sup> Herein, we report a patient with galloping tongue syndrome carrier of a mutation in the <i>PRRT2</i> gene. </p> <div class="clinicalfindings" title="sec"> <div class="title" tagx="title" title="title">
Clinical findings</div> <p>A 17-year-old woman presented with involuntary tongue movements within the past years, appearing only with tongue protrusion. "Wavy" contractions of the tongue were evident during sustained tongue protrusion ( <a href="#SM1">video 1</a>). The contractions developed immediately after sticking the tongue out, persisted during protrusion, and disappeared while at rest. The movements could not be disrupted, suppressed, or entrained with examiner-given rhythmic activities. Abrupt body movements, sleep deprivation, or coffee intake did not affect the abnormal movement. There was no history of exposure to neuroleptic medication or head trauma. The tongue contractions seemed to begin in the posterior midline region and progress in a wavy fashion to the anterior and lateral parts of the tongue. The results of routine hematologic and blood biochemistry including thyroid function tests, copper levels, and ceruloplasmin were normal. A urine toxicology screen did not reveal the presence of any drug of abuse. An electrophysiologic study with electrodes applied on the surface of the tongue showed no electrical activity while at rest. With tongue protrusion, the EMG activity was segmented in discharges of 200–300 ms duration and separated by brief periods of silence, with an approximate frequency of 3 per second ( <a href="#F1">figure 1</a>). Her brain MRI was normal. Because the movement disorder did not affect the patient's orolingual function, no treatment was started. </p> <div class="local-data" title="local-data"> <a href="https://dx.doi.org/10.1212/000377_Video_1">10.1212/000377_Video_1</a> <span class="label" tagx="label" title="label">Video 1</span>  <p>17-year-old woman with tongue movements appearing only during tongue protrusion. "Wavy" contractions of the tongue are evident during sustained tongue protrusion. <span class="inline-supplementary-material" tagx="inline-supplementary-material" title="inline-supplementary-material">Download Supplementary Video 1</span> via <a href="10.1212/000377_Video_1">http://dx.doi.org/10.1212/000377_Video_1</a> </p>  </div> <div class="fig" title="fig"> <div class="figure" title="figure"> <a href="http://doi.org/"> <span class="label" tagx="label" title="label">Figure 1</span> </a> </div>   <div class="title" tagx="title" title="title">
Electromyographic activity of the tongue recorded with surface electrodes during tongue protrusion </div> <p>Discharges of 200–300 ms duration and separated by brief periods of silence, with an approximate frequency of 3 per second were observed during tongue protrusion. Broken lines have been added to underline each EMG discharge. </p>   </div> <p>The patient's sister, a 14-year-old, presented with short episodes of choreo-dystonic movements of the left arm and neck that appeared when she started to run since the age of 10. These episodes usually last a few seconds and occur at least 10 times per day. Her consciousness level was normal during episodes. Her medical history included migraine. She was diagnosed as having paroxysmal kinesigenic dyskinesias (PKD). Treatment with carbamazepine led to a complete remission of the movements. </p> <p>There was no family history of epilepsy or infantile convulsions. The patient's mother had severe recurrent migraine headaches. Her maternal cousin had been diagnosed with PKD. </p> <p>The patient, her 2 sisters (1 healthy and the other affected with PKD), and their mother were available for <i>PRRT2</i> mutation screen ( <a href="#F2">figure 2</a>). Direct sequencing identified a heterozygous truncating mutation in the proband, her mother, and the symptomatic sister: GRC37/hg19: chr16:29825025 GA/A, NM_145239: c.650delG, producing the amino acid change NP_660282.2: p.R217Qfs*12. This variant is not listed in public genomic databases, including ExAC ( <a href="http://exac.broadinstitute.org/)">exac.broadinstitute.org/</a>). </p> <div class="fig" title="fig"> <div class="figure" title="figure"> <a href="http://doi.org/"> <span class="label" tagx="label" title="label">Figure 2</span> </a> </div>   <div class="title" tagx="title" title="title"> <i>PRRT2</i> mutational analysis in a family with paroxysmal neurologic disorder </div> <p>Right, <i>PRRT2</i> electropherograms: Top, wildtype sequence in the proband's healthy sister; and bottom, guanine deletion at position 650 occurs at the end of a cytosine streak, a well-known hotspot in PKD. The variant results in a premature termination of transcription (p.R217Qfs*12). Left, family tree with various phenotypes indicated. </p>   </div> </div> <div class="discussion" title="discussion"> <div class="title" tagx="title" title="title">
Discussion</div> <p>Herein, we describe a patient with "galloping tongue" syndrome who was positive for the p.R217Q fs*12 mutation in the <i>PRRT2</i> gene. Galloping tongue is an uncommon movement disorder. <sup> <a href="#R1">1</a> <a href="#R2">–</a> <a href="#R5">5</a> </sup> The characteristics of these lingual movements have been variably described as transverse contractions, twisting, or undulating movements. <sup> <a href="#R2">2</a> <a href="#R3">–</a> <a href="#R5">5</a> </sup> Although these movements were present with the tongue at rest in most of the reported patients, in some cases the movements were also observed during sustained action. </p> <p>Our patient had a mutation in the <i>PRRT2</i> gene known to be associated with PKD. <sup> <a href="#R6">6</a> </sup> However, she did not have the typical paroxysmal dyskinesias seen in PKD. Her abnormal movements were triggered by action but were not paroxysmal because they were present as long as the voluntary movement motion persisted, resembling an action dystonia. The topography of dyskinesia, isolated to the tongue, was also uncharacteristic of PKD. Still, we believe that the <i>PRRT2</i> mutation could be linked to the patient's movement disorder because it is action related and known causes of the disorder have been ruled out. Furthermore, the phenotype of <i>PRRT2</i> mutations is not limited to dystonia and chorea typical of PKD, but episodic ataxia and paroxysmal torticollis have also been described. <sup> <a href="#R7">7</a> </sup> Seizures and migraine seem to be also part of the clinical spectrum. <sup> <a href="#R6">6</a> </sup> </p> <p>The cause of the lingual movements in our patient remains uncertain. A functional movement disorder seemed unlikely because the movement disorder could not be disrupted, suppressed, or entrained with examiner maneuvers, which had no impact in the patient's life, and there was no obvious gain for the patient. The study of similar cases and additional <i>PRRT2</i> families will eventually clarify whether the "galloping tongue" syndrome is indeed a previously unrecognized manifestation of <i>PRRT2</i> mutations. </p> </div> </div> <div class="back" title="back"> <div class="contribution" title="contribution"> <div class="title" tagx="title" title="title">
Author contributions</div> <p content-type="contribution">D. Vilas and E. Tolosa: drafting/revising the manuscript and conceptualization of the study. A. Marcé-Grau and A. Macaya: genetic analysis and revising the manuscript. J. Vall-Solé: electrophysiologic study and revising the manuscript. </p> </div> <div class="funding" title="funding"> <div class="title" tagx="title" title="title">
Study funding</div> <p content-type="funding">No targeted funding reported.</p> </div> <div class="disclosure" title="disclosure"> <div class="title" tagx="title" title="title">
Disclosure</div> <p content-type="disclosure">Disclosures available: <a href="https://ng.neurology.org/content/5/6/e377/tab-article-info">Neurology.org/NG</a>. </p> </div> <div class="references">
References</div> <div tag="ref-list"> <ul> <div class="title" tagx="title" title="title">
References</div> <li tag="ref"> <a name="R1" /> <span class="label" tagx="label" title="label">1.</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Keane</span> <span class="given-names" tagx="given-names" title="given-names">JR</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Galloping tongue: post-traumatic, episodic, rhythmic movements</span>. <span class="source" tagx="source" title="source">Neurology</span> <span class="year" tagx="year" title="year">1984</span>; <span class="volume" tagx="volume" title="volume">34</span>: <span class="fpage" tagx="fpage" title="fpage">251</span>– <span class="lpage" tagx="lpage" title="lpage">252</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/6538022">6538022</a> </span> </span> </li> <li tag="ref"> <a name="R2" /> <span class="label" tagx="label" title="label">2.</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Saddichha</span> <span class="given-names" tagx="given-names" title="given-names">BA</span> </span>, <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Talukdar</span> <span class="given-names" tagx="given-names" title="given-names">D</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Serpentine tongue syndrome associated with risperidone long-acting injection treatment</span>. <span class="source" tagx="source" title="source">J Clin Psychopharmacol</span> <span class="year" tagx="year" title="year">2014</span>; <span class="volume" tagx="volume" title="volume">34</span>: <span class="fpage" tagx="fpage" title="fpage">657</span>– <span class="lpage" tagx="lpage" title="lpage">658</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/25118081">25118081</a> </span> </span> </li> <li tag="ref"> <a name="R3" /> <span class="label" tagx="label" title="label">3.</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Nagappa</span> <span class="given-names" tagx="given-names" title="given-names">M</span> </span>, <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Sinha</span> <span class="given-names" tagx="given-names" title="given-names">S</span> </span>, <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Saini</span> <span class="given-names" tagx="given-names" title="given-names">J</span> </span>, <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Bindu</span> <span class="given-names" tagx="given-names" title="given-names">P</span> </span>, <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Taly</span> <span class="given-names" tagx="given-names" title="given-names">A</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Undulating tongue in Wilson's disease</span>. <span class="source" tagx="source" title="source">Ann Indian Acad Neurol</span> <span class="year" tagx="year" title="year">2014</span>; <span class="volume" tagx="volume" title="volume">17</span>: <span class="fpage" tagx="fpage" title="fpage">225</span>– <span class="lpage" tagx="lpage" title="lpage">226</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/25024581">25024581</a> </span> </span> </li> <li tag="ref"> <a name="R4" /> <span class="label" tagx="label" title="label">4.</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Prashantha</span> <span class="given-names" tagx="given-names" title="given-names">DK</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Serpentingue tongue: a rare manifestation following initiation of levodopa therapy in a patient with Parkinson's disease </span>. <span class="source" tagx="source" title="source">Parkinsonism Relat Disord</span> <span class="year" tagx="year" title="year">2009</span>; <span class="volume" tagx="volume" title="volume">15</span>: <span class="fpage" tagx="fpage" title="fpage">718</span>– <span class="lpage" tagx="lpage" title="lpage">719</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/19157953">19157953</a> </span> </span> </li> <li tag="ref"> <a name="R5" /> <span class="label" tagx="label" title="label">5.</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Sheehy</span> <span class="given-names" tagx="given-names" title="given-names">SHC</span> </span>, <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Lawrence</span> <span class="given-names" tagx="given-names" title="given-names">T</span> </span>, <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Thevathasan</span> <span class="given-names" tagx="given-names" title="given-names">AW</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Serpentine tongue. A lingual dyskinesia</span>. <span class="source" tagx="source" title="source">Neurology</span> <span class="year" tagx="year" title="year">2008</span>; <span class="volume" tagx="volume" title="volume">70</span>: <span class="fpage" tagx="fpage" title="fpage">e87</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/18490612">18490612</a> </span> </span> </li> <li tag="ref"> <a name="R6" /> <span class="label" tagx="label" title="label">6.</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Méneret</span> <span class="given-names" tagx="given-names" title="given-names">A</span> </span>, <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Grabli</span> <span class="given-names" tagx="given-names" title="given-names">D</span> </span>, <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Depienne</span> <span class="given-names" tagx="given-names" title="given-names">C</span> </span>, <span class="etal" title="etal"> <i>et al.</i> </span> </span> <span class="mixed-article-title" title="mixed-article-title">PRRT2 mutations: a major cause of paroxysmal kinesigenic dyskinesia in the European population </span>. <span class="source" tagx="source" title="source">Neurology</span> <span class="year" tagx="year" title="year">2012</span>; <span class="volume" tagx="volume" title="volume">79</span>: <span class="fpage" tagx="fpage" title="fpage">170</span>– <span class="lpage" tagx="lpage" title="lpage">174</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/22744660">22744660</a> </span> </span> </li> <li tag="ref"> <a name="R7" /> <span class="label" tagx="label" title="label">7.</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Castelnovo</span> <span class="given-names" tagx="given-names" title="given-names">G</span> </span>, <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Renard</span> <span class="given-names" tagx="given-names" title="given-names">D</span> </span>, <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">De Verdal</span> <span class="given-names" tagx="given-names" title="given-names">M</span> </span>, <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Luc</span> <span class="given-names" tagx="given-names" title="given-names">J</span> </span>, <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Thouvenot</span> <span class="given-names" tagx="given-names" title="given-names">E</span> </span>, <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Riant</span> <span class="given-names" tagx="given-names" title="given-names">F</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Progressive ataxia related to PRRT2 gene mutation</span>. <span class="source" tagx="source" title="source">J Neurol Sci</span> <span class="year" tagx="year" title="year">2016</span>; <span class="volume" tagx="volume" title="volume">367</span>: <span class="fpage" tagx="fpage" title="fpage">220</span>– <span class="lpage" tagx="lpage" title="lpage">221</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/27423591">27423591</a> </span> </span> </li> </ul> </div> </div>  </body></html>